In addition to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection
itself, an increase in the incidence of antimicrobial resistance poses collateral damage to the …

Background: Coronavirus disease 2019 (COVID-19) and tuberculosis (TB) are two major
infectious diseases posing significant public health threats, and their coinfection (aptly …

Introduction The COVID-19 outbreak poses a significant threat to the patients with
tuberculosis (TB). TB and COVID-19 (TB–COVID) coinfection means the disease caused by …

Background Pulmonary radiological findings of the novel coronavirus disease 2019 (COVID-
19) have been well documented and range from scattered ground-glass infiltrates in milder …

Background and aim Coronavirus disease 2019 (COVID-19) coinfection with other
respiratory pathogens poses a serious concern that can complicate diagnosis, treatment …

Coronavirus disease-2019 (COVID-19), caused by SARS-CoV-2, is an infectious disease
that poses severe threats to global public health and significant economic losses. The …

Background Tuberculosis (TB) is still one of the most important causes of death worldwide.
The lack of timely attention on TB diagnosis and treatment during the coronavirus disease …

Introduction: The pressure of the COVID-19 pandemic on healthcare systems led to limited
roles of infectious diseases services, increased rates of irrational use of antimicrobials, and …

Background: Tuberculosis, like COVID-19, is most often a pulmonary disease. The COVID-
19 pandemic has severely disrupted tuberculosis services in myriad ways: health facility …

Plasmodium vivax (P. vivax) is a protozoan parasite that causes vivax malaria. Disease
relapse post-treatment is reported in P. vivax co-infection with other bacterial and parasitic …